4//SEC Filing
Corcoran Gavin 4
Accession 0001636050-19-000086
CIK 0001636050other
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 5:15 PM ET
Size
5.8 KB
Accession
0001636050-19-000086
Insider Transaction Report
Form 4
Corcoran Gavin
EVP of R&D
Transactions
- Award
Restricted Stock Units
2019-09-21+32,003→ 32,003 total→ Common Shares (32,003 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the right to receive one share of the Issuer's common stock.
- [F2]50% of the common shares underlying the restricted stock units vest on January 31, 2020 and the remainder vest on July 31, 2020, subject to the Reporting Person providing continuous service to the Issuer through each such date.
Documents
Issuer
Axovant Gene Therapies Ltd.
CIK 0001636050
Entity typeother
Related Parties
1- filerCIK 0001745995
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 5:15 PM ET
- Size
- 5.8 KB